Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population

Background: Chronic obstructive pulmonary disease (COPD) is associated with a progressive loss of muscle mass and function and a systemic inflammatory process that can cause sarcopenia. Objective: The objective of this study is to estimate the prevalence rate of sarcopenia in COPD patients and to de...

Full description

Bibliographic Details
Main Authors: Maria Tsekoura, Elias Tsepis, Evdokia Billis, John Gliatis
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Lung India
Subjects:
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=6;spage=479;epage=484;aulast=Tsekoura
_version_ 1819225405174841344
author Maria Tsekoura
Elias Tsepis
Evdokia Billis
John Gliatis
author_facet Maria Tsekoura
Elias Tsepis
Evdokia Billis
John Gliatis
author_sort Maria Tsekoura
collection DOAJ
description Background: Chronic obstructive pulmonary disease (COPD) is associated with a progressive loss of muscle mass and function and a systemic inflammatory process that can cause sarcopenia. Objective: The objective of this study is to estimate the prevalence rate of sarcopenia in COPD patients and to determine the factors associated with sarcopenic patients living in Western Greece. Methods: European Working Group on Sarcopenia in Older People criteria were applied to 69 outpatients with stable COPD. Body composition, exercise capacity, functional performance, physical activity, and health status were also assessed. COPD disease severity (COPD stage) was evaluated with the Global Initiative for chronic obstructive lung disease. The study protocol was approved by the Ethical Committee of the Technological Educational Institute of Western Greece. Results: The sample comprised 69 patients (59 women and 10 men), with a mean age of 71.33 ± 7.48 years. The prevalence of sarcopenia was 24.6% (n = 17). A high percentage (82.6%; n = 57) of the 69 Greek participants did not perform any regular exercise. The findings of this study demonstrated that sarcopenia was positively associated with COPD, age, body mass index, skeletal muscle mass, hand grip strength, and 4 m test. Conclusions: In conclusion, there is a 24.6% prevalence of sarcopenia in patients with COPD. Further research with larger samples would be indicated to clarify the precise association of specific characteristics of patients with sarcopenia and COPD.
first_indexed 2024-12-23T10:09:04Z
format Article
id doaj.art-466920e3943141408430f517f0b27fc7
institution Directory Open Access Journal
issn 0970-2113
0974-598X
language English
last_indexed 2024-12-23T10:09:04Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Lung India
spelling doaj.art-466920e3943141408430f517f0b27fc72022-12-21T17:51:00ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2020-01-0137647948410.4103/lungindia.lungindia_143_20Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek populationMaria TsekouraElias TsepisEvdokia BillisJohn GliatisBackground: Chronic obstructive pulmonary disease (COPD) is associated with a progressive loss of muscle mass and function and a systemic inflammatory process that can cause sarcopenia. Objective: The objective of this study is to estimate the prevalence rate of sarcopenia in COPD patients and to determine the factors associated with sarcopenic patients living in Western Greece. Methods: European Working Group on Sarcopenia in Older People criteria were applied to 69 outpatients with stable COPD. Body composition, exercise capacity, functional performance, physical activity, and health status were also assessed. COPD disease severity (COPD stage) was evaluated with the Global Initiative for chronic obstructive lung disease. The study protocol was approved by the Ethical Committee of the Technological Educational Institute of Western Greece. Results: The sample comprised 69 patients (59 women and 10 men), with a mean age of 71.33 ± 7.48 years. The prevalence of sarcopenia was 24.6% (n = 17). A high percentage (82.6%; n = 57) of the 69 Greek participants did not perform any regular exercise. The findings of this study demonstrated that sarcopenia was positively associated with COPD, age, body mass index, skeletal muscle mass, hand grip strength, and 4 m test. Conclusions: In conclusion, there is a 24.6% prevalence of sarcopenia in patients with COPD. Further research with larger samples would be indicated to clarify the precise association of specific characteristics of patients with sarcopenia and COPD.http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=6;spage=479;epage=484;aulast=Tsekouraairway obstructionlung diseasesarcopeniaskeletal muscle mass
spellingShingle Maria Tsekoura
Elias Tsepis
Evdokia Billis
John Gliatis
Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population
Lung India
airway obstruction
lung disease
sarcopenia
skeletal muscle mass
title Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population
title_full Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population
title_fullStr Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population
title_full_unstemmed Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population
title_short Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population
title_sort sarcopenia in patients with chronic obstructive pulmonary disease a study of prevalence and associated factors in western greek population
topic airway obstruction
lung disease
sarcopenia
skeletal muscle mass
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=6;spage=479;epage=484;aulast=Tsekoura
work_keys_str_mv AT mariatsekoura sarcopeniainpatientswithchronicobstructivepulmonarydiseaseastudyofprevalenceandassociatedfactorsinwesterngreekpopulation
AT eliastsepis sarcopeniainpatientswithchronicobstructivepulmonarydiseaseastudyofprevalenceandassociatedfactorsinwesterngreekpopulation
AT evdokiabillis sarcopeniainpatientswithchronicobstructivepulmonarydiseaseastudyofprevalenceandassociatedfactorsinwesterngreekpopulation
AT johngliatis sarcopeniainpatientswithchronicobstructivepulmonarydiseaseastudyofprevalenceandassociatedfactorsinwesterngreekpopulation